3 Problems Doctors Face When Prescribing Medical Marijuana

By Admin
Medical marijuana has been a controversial topic amongst physicians for decades, but with more and more states legalizing the therapeutic drug doctors n...

Medical marijuana has been a controversial topic amongst physicians for decades, but with more and more states legalizing the therapeutic drug doctors need to inform themselves if prescribing cannabis is the right thing to do.

Ziva D. Cooper, PhD, Assistant Professor of Clinical Neurology at Columbia University, is intrigued by the enduring power of psychoactive substances to maintain drug-taking behavior. She believes there are three major limitations doctors face when prescribing medical marijuana and shared her insight on The Doctors Channel.

Dr. Cooper explained that a lack of controlled studies and unknown risks to pulmonary health are the main concerns for many doctors.

Here are the three problems doctors face when prescribing medical marijuana.

Problem 1: There have not been double blind, placebo controlled studies demonstrating the efficacy of marijuana for the number of indications for which it is prescribed.

“To take it one step further, there also haven’t been studies to determine that marijuana is better than some of the other medications that are on the market,” said Cooper. “So this is an important consideration when deciding to prescribe a patient medical marijuana.”

Problem 2: There are risks to using medical marijuana including dependence and the fact that smoking anything will compromise pulmonary health.

“If somebody is opting for the medical marijuana route, some things to consider would be, let’s say, vaporizing,” Cooper said. “Whenever somebody smokes anything, there’s this carbon monoxide expiration and this is an indication that it’s not necessarily a good thing to do. When somebody vaporizes, the carbon monoxide levels are negligible.”

Problem 3: Marijuana is not necessarily controlled and studied in terms of the different chemicals that are in it.

“Different strains have different names and actually now there are services that are provided that can use methods to detect how much THC is in each strain [and] how much cannabidiol is in each strain,” Cooper added. “But when a patient goes to a medical dispensary, they might not necessarily know all the other components that are in there or how much THC is in that strain.”   


Featured Articles

Costco Weight-Loss Drugs Move Highlights US AOM Growth

Costco move to partner with online healthcare provider Sesame to provide members with weight-loss drugs including Wegovy signals US anti-obesity boom

AstraZeneca Company Profile, as CEO Soriot Lands pay Deal

As it's announced AstraZeneca's CEO Pascal Soriot's package could rise by as much as US$24mn we explore the history of the UK's most valuable business

US Academic Medical Centres 'Struggling' says McKinsey

McKinsey report reveals cost inflation is forcing AMCs to find operational efficiencies, or face cutting back on crucial training & education programmes

J&J Community Initiatives Tackle US Healthcare Chasm

Medical Devices & Pharma

PitchBook: Healthcare Private Equity Deals see Decline

Health Insurance & Finance

McKinsey: ‘Women’s Healthcare Neglected for Decades'

Digital Healthcare